3-39143660-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_033027.4(CSRNP1):c.1165G>A(p.Asp389Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000083 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033027.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSRNP1 | NM_033027.4 | c.1165G>A | p.Asp389Asn | missense_variant | Exon 5 of 5 | ENST00000273153.10 | NP_149016.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSRNP1 | ENST00000273153.10 | c.1165G>A | p.Asp389Asn | missense_variant | Exon 5 of 5 | 1 | NM_033027.4 | ENSP00000273153.5 | ||
CSRNP1 | ENST00000514182.1 | c.1165G>A | p.Asp389Asn | missense_variant | Exon 5 of 5 | 1 | ENSP00000422532.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152162Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250688Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135524
GnomAD4 exome AF: 0.0000848 AC: 124AN: 1461880Hom.: 0 Cov.: 83 AF XY: 0.0000784 AC XY: 57AN XY: 727242
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152162Hom.: 0 Cov.: 34 AF XY: 0.0000673 AC XY: 5AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1165G>A (p.D389N) alteration is located in exon 5 (coding exon 4) of the CSRNP1 gene. This alteration results from a G to A substitution at nucleotide position 1165, causing the aspartic acid (D) at amino acid position 389 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at